Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.0B | 15.6B | 15.7B | 16.7B |
Cost of revenue | 11.0B | 11.1B | 11.5B | 11.5B |
Gross profit | 3.0B | 4.4B | 4.1B | 5.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 676M | 1.0B | 963M | 1.2B |
Other operating expenses | 1.8B | 1.7B | 1.8B | 1.7B |
Operating income | 569M | 1.7B | 1.4B | 2.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 179M | 180M | 173M | 188M |
Other income expense | -70M | -335M | 337M | -306M |
Pretax income | 320M | 1.2B | 1.6B | 1.8B |
Tax provision | 80M | 359M | 289M | 468M |
Net income | 240M | 843M | 1.3B | 1.3B |
Basic EPS | 0.4 | 1.3 | 2.0 | 2.0 |
Diluted EPS | 0.4 | 1.3 | 2.0 | 2.0 |
Basic average shares | 721.5M | 719.2M | 718.1M | 718.1M |
Diluted average shares | 730.4M | 730.4M | 724.8M | 726.0M |
EBITDA | 539M | 1.6B | 1.4B | 2.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |